Legal Marijuana plan to be released Thursday United Nations Warn US & Canada On Legal Marijuana Canada marijuana takes big step with federal report now complete Pharma executive behind OxyContin sells medical marijuana “3 Grams A Day” Canada Tells Veterans Who Use Marijuana Canopy Growth becomes Canada’s first marijuana unicorn, worth $1 billion Canadian Health Insurance Co. Says Yes to Covering Cannabis Costs Canada’s marijuana legalization plan flouts 3 UN drug conventions Will Canada become America’s cannabis capital? Canadian marijuana producer expands abroad Loblaw looks to get in on medical marijuana business Veterans Affairs must better manage drug plan, marijuana costs Let people smoke pot outside, says Colorado legislator Vancouver medical marijuana businesses must close by Friday if breaking rules Canadian Marijuana Companies Make Millions — But They Can’t Get a Bank Account Race to Develop Marijuana Breathalyzers Before Canada Legalizes Drug Canada is planning to decriminalize marijuana by 2017 U.S. experts urge Canada to cultivate social standards around marijuana Canada’s first national marijuana advertisement Canadian Pharmacists Association Eyes Medical Marijuana Canada’s Weed Policy Shows Way Forward On Blockchain Regulations Demand for Canada medical marijuana growing Four Canadians plead guilty to smuggling weed in Barbados Marijuana Helps Arthritis Using Medical Marijuana for Fibromyalgia Omission of marijuana reform in budget not a stall tactic – Ottawa Alberta liquor stores contemplating marijuana sales Canada Marijuana Infused Nutella – Chrontella Now Available Canadian Cannabis Producer Supreme Pharma Prepares to Enter Market Canadian official causes stir with ‘progressive’ speech at UN narcotics conference Teen marijuana use in Canada in decade decline Veterans’ marijuana prescriptions rise tenfold in 2 years, Ottawa asks questions Marijuana Drug Found to Reduce Epileptic Seizures Marijuana industry busily working to shed troubled past and go legal Legal history of marijuana in Canada Marapharm Ventures Acquires Growing Marijuana Business in Washington State Vancouver’s marijuana shops look toward Toronto Over 22,000 Marijuana Arrests Under Trudeau So Far Ontario government frowns on vaping and medical marijuana in public Squamish Council considers marijuana rules Health Canada awards company a hemp license Marijuana legalization in Canada is coming – Someday Legalize marijuana possession NOW! Legalizing marijuana: Health Canada flags 9 factors for Liberals to consider Canadian marijuana firms say illegal rivals costing them money Majority of Canadians agree pot should be legal Renowned chef stopped at Canadian border with over 20 pounds of marijuana edibles Shoppers Drug Mart eyes sales of Medical Marijuana Canadians Can Grow Their Own Medical Marijuana, Court Rules Halifax councilor takes on neighbor’s medical marijuana fight Princess Margaret pulls prize home from lottery – marijuana grow-op License appeals begin for Vancouver marijuana dispensaries Canada’s police chiefs want feds to remind people marijuana isn’t legal yet More palliative care patients should get medical marijuana: doctors Unlicensed medical marijuana sellers must still pay tax, appeal court rules Licensed pot shops coming to Vancouver as early as March Police seize $378K worth of marijuana plants from Winnipeg home Quebec backtracks on refusal to help legalize marijuana

Marijuana Drug Found to Reduce Epileptic Seizures

epilectic seizure - Copy

An experimental drug derived from marijuana has succeeded in reducing epileptic seizures in its first major clinical trial, the product’s developer announced on Monday, a finding that could lend credence to the medical marijuana movement.

The developer, GW Pharmaceuticals, said the drug, Epidiolex, achieved the main goal of the trial, reducing convulsive seizures when compared with a placebo in patients with Dravet syndrome, a rare form of epilepsy. GW shares more than doubled on Monday.

If Epidiolex wins regulatory approval, it would be the first prescription drug in the United States that is extracted from marijuana. The drug is a liquid containing cannabidiol, a component of marijuana that does not make people high.

As many as 30 percent of the nearly 500,000 American children with epilepsy are not sufficiently helped by existing drugs, according to GW. Parents of some of these children have been flocking to try marijuana extracts, prepared by medical marijuana dispensaries.
A number of states, in response to pressure from these parents, have passed or considered legislation to make it easier to obtain marijuana-based products. And some families have become “marijuana refugees,” moving to Colorado where it has been easier to obtain a particular extract, known as Charlotte’s Web, after the girl who first used it to control seizures.

Hundreds of other children and young adults have been using Epidiolex outside of clinical trials, under programs that allow desperate patients to use experimental drugs.

While many parents have reported significant reductions in seizures, experts have been cautious about anecdotal reports, saying that such treatments needed to be compared with a placebo to make sure they work. As such, the results from the GW trial have been closely watched.

“I’m very proud and happy about this study because it is science — we did things the way they should be done,” the study’s lead investigator, Dr. Orrin Devinsky of the Comprehensive Epilepsy Center at New York University Langone Medical Center, said in an interview. “I would strongly advocate that in the United States we need to do systematic assessments of medical marijuana.”

The study involved 120 patients with an average age of 10 and an average frequency of 13 convulsive seizures a month at the start of the study, despite taking an average of three other drugs. Half of the children were randomly assigned to take the drug and the other half the placebo, in addition to the epilepsy medicines they were already taking.
The company said that for the patients who received Epidiolex, the frequency of convulsive seizures fell by 39 percent during the 14-week treatment period, compared with a four-week period just before the treatment started. For those getting the placebo, the reduction was 13 percent. The difference between the two groups was statistically significant.

Eight patients getting Epidiolex and one getting the placebo withdrew from the trial because of side effects. Major side effects included drowsiness, diarrhea, decreased appetite, fatigue, fever, vomiting and upper respiratory infection. But GW said that over all, the drug was well tolerated.
One caution is that the full details of the study were not released; the company said they would be presented at a medical conference.

Read the Rest

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright 2016 www.mymarijuananews.com